All Stories

  1. Sigma-2 Receptor Ligand Binding Modulates Association between TSPO and TMEM97
  2. Finding flow: unpacking the capacity of in-lecture question activities to engage online students
  3. Quo vadis PGRMC? Grand-Scale Biology in Human Health and Disease
  4. Unde venisti PGRMC? Grand-Scale Biology from Early Eukaryotes and Eumetazoan Animal Origins
  5. Structural characterisation of a MAPR ‐related archaeal cytochrome b 5M protein
  6. Structural characterization of a MAPR-related archaeal cytochrome b5M protein
  7. MAPR origins reveal a new class of prokaryotic cytochrome b5 proteins and possible role in eukaryogenesis
  8. PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling
  9. PGRMC Proteins Are Coming of Age: A Special Issue on the Role of PGRMC1 and PGRMC2 in Metabolism and Cancer Biology
  10. Proceedings from the Fourth International Symposium on σ-2 Receptors: Role in Health and Disease
  11. Choose your partners for the next dance: implied PGRMC1 roles in membrane trafficking and mitochondrial modulation
  12. PGRMC1 has crucial roles in animal biology and disease
  13. PGRMC1 phosphorylation is a master regulator of cell functions
  14. Evolutionary history of PGRMC1-like MAPR proteins
  15. PGRMC1 effects on metabolism, genomic mutation and CpG methylation imply crucial roles in animal biology and disease
  16. PGRMC1 protein interacts with proteins of the actin cytoskeleton
  17. Early eukaryotic origins and metazoan elaboration of MAPR family proteins
  18. Fine needle aspiration biopsy cytology of phyllodes tumour and fibroadenoma: A cytomorphological study of 104 cases
  19. Thoughts on interactions between PGRMC1 and diverse attested and potential hydrophobic ligands
  20. The evolutionary appearance of signaling motifs in PGRMC1
  21. PGRMC1regulates multiple important processes in disease processes
  22. Deconstructing autofluorescence: non-invasive detection and monitoring of biochemistry in cells and tissues (Conference Presentation)
  23. Quantitative non-invasive cell characterisation and discrimination based on multispectral autofluorescence features
  24. Non-invasive detection and monitoring of biochemistry in cells and tissues by decomposing autofluorescence
  25. As I predicted in 2008, this protein appears to be regulated by phosphorylation.
  26. Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
  27. Multiphoton fluorescence lifetime imaging microscopy reveals free-to-bound NADH ratio changes associated with metabolic inhibition
  28. Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1
  29. Overexpression of progesterone receptor membrane component 1
  30. Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells
  31. Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells
  32. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells
  33. The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells
  34. New insight on a possible mechanism of progestogens in terms of breast cancer risk
  35. A Bifunctional Role for Group IIA Secreted Phospholipase A2 in Human Rheumatoid Fibroblast-like Synoviocyte Arachidonic Acid Metabolism
  36. Erratum to: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
  37. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells
  38. Differential ProteoTope Radioactive Quantification of Protein Abundance Ratios
  39. Serial Immobilized pH Gradient Isoelectric Focusing over pH 4–9
  40. Protein Expression Profiling in Esophageal Adenocarcinoma Patients Indicates Association of Heat-Shock Protein 27 Expression and Chemotherapy Response
  41. Increased wound-response revealed by proteomics of estrogen receptor-negative breast cancers
  42. Expression and functional analysis of PGRMC1 in breast cancer
  43. Breast cancer proteomics reveals correlation between Estrogen Receptor status and differential phosphorylation of PGRMC1
  44. Metabolically stable isotope labeling prior to electrophoretic protein separation reveals differences in fractional synthesis rates between mitochondrial aldehyde dehydrogenase isoforms
  45. Progesterone receptor membrane component 1: An integrative review
  46. Differential radioactive quantification of protein abundance ratios between benign and malignant prostate tissues: Cancer association of annexin A3
  47. Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection
  48. Comparative Profiling of the Mammalian Mitochondrial Proteome:  Multiple Aconitase-2 Isoforms Including N-formylkynurenine Modifications as Part of a Protein Biomarker Signature for Reactive Oxidative Species
  49. Differential Radioactive Proteomic Analysis of Microdissected Renal Cell Carcinoma Tissue by 54 cm Isoelectric Focusing in Serial Immobilized pH Gradient Gels
  50. Isoelectric focusing in serial immobilized pH gradient gels to improve protein separation in proteomic analysis
  51. Determination of Fractional Synthesis Rates of Mouse Hepatic Proteins via Metabolic 13 C-Labeling, MALDI-TOF MS and Analysis of Relative Isotopologue Abundances Using Average Masses
  52. Differential and quantitative molecular analysis of ischemia complexity reduction by isotopic labeling of proteins using a neural embryonic stem cell model
  53. Global proteomic approach unmasks involvement of keratins 8 and 18 in the delivery of cystic fibrosis transmembrane conductance regulator (CFTR)/?F508-CFTR to the plasma membrane
  54. Potential of Comprehensive Toxico-proteomics: Quantitative and Differential Mining of Functional Proteomes from Native Samples
  55. Identifikation differentiell exprimierter Proteine in unterschiedlichen Progressionsstufen von Mammakarzinomgewebe mittels Lasermikrodissektion und Proteomanalyse
  56. Protein abundance quantification in embryonic stem cells using incomplete metabolic labelling with15N amino acids, matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry, and analysis of relative isotopologue abundances of peptides
  57. Analysis of relative isotopologue abundances for quantitative profiling of complex protein mixtures labelled with the acrylamide/D3-acrylamide alkylation tag system
  58. Isoelectric focusing in long immobilized pH gradient gels to improve protein separation in proteomic analysis
  59. Improved sensitivity proteomics by postharvest alkylation and radioactive labeling of proteins
  60. Improved sensitivity proteomics by postharvest alkylation and radioactive labeling of proteins
  61. MAPKAP Kinase 2 Phosphorylates Serum Response Factor in Vitro and in Vivo
  62. Antioxidants As Well As Oxidants Activate C-fos Via Ras-Dependent Activation of Extracellular-Signal-Regulated Kinase 2 and Elk-1
  63. c-Fos transrepression revisited
  64. Crosslinking of SRF to the c-fosSRE CArG Box Guanines Using Photo-active Thioguanine Oligodeoxynucleotides
  65. Signalling pathways: Jack of all cascades
  66. MADS-Domain Transcription Factors and their Accessory Proteins (TCFS)
  67. The Transcription Factor TCF/Elk-1
  68. Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1.
  69. Transcriptional repression mediated by the serum response factor
  70. Signal integration at the c- fos promoter
  71. Signal uptake by the c-fos serum response element
  72. Co-occurrence of CArG Boxes and TCF Sites within Viral Genomes
  73. Regulatory squelching
  74. Proteomic Expression Profiling of Breast Cancer